1. Home
  2. MYND vs SCLX Comparison

MYND vs SCLX Comparison

Compare MYND & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • SCLX
  • Stock Information
  • Founded
  • MYND 1998
  • SCLX 2011
  • Country
  • MYND United States
  • SCLX United States
  • Employees
  • MYND N/A
  • SCLX N/A
  • Industry
  • MYND Other Consumer Services
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYND Real Estate
  • SCLX Health Care
  • Exchange
  • MYND Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • MYND 42.3M
  • SCLX 33.9M
  • IPO Year
  • MYND 2017
  • SCLX N/A
  • Fundamental
  • Price
  • MYND $0.90
  • SCLX $6.36
  • Analyst Decision
  • MYND
  • SCLX Strong Buy
  • Analyst Count
  • MYND 0
  • SCLX 3
  • Target Price
  • MYND N/A
  • SCLX $367.50
  • AVG Volume (30 Days)
  • MYND 14.2K
  • SCLX 113.1K
  • Earning Date
  • MYND 08-28-2025
  • SCLX 08-12-2025
  • Dividend Yield
  • MYND N/A
  • SCLX N/A
  • EPS Growth
  • MYND N/A
  • SCLX N/A
  • EPS
  • MYND N/A
  • SCLX N/A
  • Revenue
  • MYND $267,380,999.00
  • SCLX $50,710,000.00
  • Revenue This Year
  • MYND N/A
  • SCLX $107.00
  • Revenue Next Year
  • MYND N/A
  • SCLX $82.52
  • P/E Ratio
  • MYND N/A
  • SCLX N/A
  • Revenue Growth
  • MYND N/A
  • SCLX 7.79
  • 52 Week Low
  • MYND $0.61
  • SCLX $3.60
  • 52 Week High
  • MYND $3.89
  • SCLX $78.05
  • Technical
  • Relative Strength Index (RSI)
  • MYND 50.43
  • SCLX 61.17
  • Support Level
  • MYND $0.83
  • SCLX $5.72
  • Resistance Level
  • MYND $0.97
  • SCLX $6.39
  • Average True Range (ATR)
  • MYND 0.10
  • SCLX 0.42
  • MACD
  • MYND -0.01
  • SCLX 0.13
  • Stochastic Oscillator
  • MYND 47.37
  • SCLX 94.23

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: